Stephanie Staelens
22Patents
5h-index
31Co-inventors
65Inventor score
Filing activity: Apr 16, 2009 → May 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8962807B2 | Single variable domain antibodies against OX40L, constructs and therapeutic use | Emerging Cross-Sectional Technologies | 24 | Active |
| US10858418B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | Physics | 12 | Active |
| US8945567B2 | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections | Chemistry; Metallurgy | 7 | Active |
| US9328174B2 | Chemokine receptor binding polypeptides | Chemistry; Metallurgy | 7 | Active |
| US8217140B2 | Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same | Chemistry; Metallurgy | 5 | Active |
| US9803001B2 | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections | Chemistry; Metallurgy | 4 | Active |
| US11414481B2 | Serum albumin binders | Chemistry; Metallurgy | 3 | Active |
| US10597449B2 | Biparatopic polypeptides antagonizing Wnt signaling in tumor cells | Chemistry; Metallurgy | 3 | Active |
| US11414480B2 | Serum albumin binding immunoglobulin single variable domains | Chemistry; Metallurgy | 3 | Active |
| US11192938B2 | Serum albumin binding proteins containing immunoglobulin single variable domains | Physics | 2 | Active |
| US11192937B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | Physics | 2 | Active |
| US11644471B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | Chemistry; Metallurgy | 1 | Active |
| US11952418B2 | Biparatopic polypeptides antagonizing Wnt signaling in tumor cells | Chemistry; Metallurgy | 1 | Active |
| US11033636B2 | Polypeptides antagonizing Wnt signaling in tumor cells | Chemistry; Metallurgy | 1 | Active |
| US9688763B2 | Chemokine receptor binding polypeptides | Chemistry; Metallurgy | 1 | Active |
| US9834611B2 | Single variable domain antibodies against OX40L, constructs and therapeutic use | Emerging Cross-Sectional Technologies | 1 | Active |
| US11897944B2 | Immunoglobulin single variable domain (ISVD) capable of binding to serum albumin | Chemistry; Metallurgy | 0 | Active |
| US12285493B2 | Polypeptides antagonizing Wnt signaling in tumor cells | Chemistry; Metallurgy | 0 | Active |
| US10822425B2 | Single variable domain antibodies against OX40L, constructs and therapeutic use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11466089B2 | Chemokine receptor binding polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11028151B2 | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections | Chemistry; Metallurgy | 0 | Active |
| US12006352B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.